US Edition
23andMe to Reopen Bankruptcy Court Auction After Anne Wojcicki Group's ...
- In March 2025, the genetic testing firm 23andMe entered bankruptcy proceedings and subsequently faced a resale auction overseen by a court in St. Louis, Missouri.
- Bankruptcy followed a failed subscription launch, a major 2023 data breach exposing information of about 6.9 million users, and debates over the fairness of the initial $256 million sale to Regeneron.
- Founder Anne Wojcicki's nonprofit TTAM Research Institute challenged the sale, proposing a $305 million bid supported by a Fortune 500 backer, leading to an agreement to reopen bidding with Regeneron able to counter at $315 million.
- 23andMe's database holds DNA from over 15 million customers, raising privacy concerns amid lack of federal privacy laws, while both bidders pledged to follow existing data policies and security commitments.
- The auction reopening marks a key moment in 23andMe's decline, with court officials calling it a positive step for equity holders and plans for a new bidding round later in June 2025.
21 Articles
21 Articles
The Mercury news
siliconvalley.comBig South Bay office building is bought, deal shows huge price plunge
SUNNYVALE — An eye-catching South Bay office building that was once the headquarters of bankrupt biotech company 23andMe has been bought at a price that reflects a massive decline in the property’s value. The office building, located at 221 North Mathilda Avenue in Sunnyvale, was bought for $87.8 million, according to documents filed on June 5 with the Santa Clara County Recorder’s Office. The new owner was able to buy the building at a price th…
The rise and fall of 23andMe
23andMe announced a reverse stock split in October.Smith Collection/GadoA class action lawsuit, resignations, and layoffs plagued 23andMe, which filed for Chapter 11 in March.Biotech company Regeneron is buying the DNA testing startup's assets for $256 million.Here's a look at the rise and fall of 23andMe.23andMe, the startup that helped usher in the era of consumer DNA test kits nearly two decades ago, filed for bankruptcy protection in March a…
23andMe Sale Takes a New Turn
The sale of genetic testing company 23andMe—which includes genetic data from around 16 million customers—took a new turn at a hearing on Wednesday. A deal for Regeneron to buy the company for $256 million was announced last month , but bidding has now been reopened. Co-founder and former CEO...
23andMe Bankruptcy Saga: Founder Anne Wojcicki Makes Last-Minute Bid for DNA Data
The saga surrounding the once-hot DNA testing company 23andMe has taken another unexpected turn. Last month, biotech firm Regeneron purchased the company’s assets—including its genetic database of around 15 million users—for $256 million at a bankruptcy auction, seemingly closing the deal. However, a larger bid from Anne Wojcicki, 23andMe’s co-founder and former CEO, has prompted a second auction. At a court hearing in St. Louis, Mo. yesterday (…
Coverage Details
Bias Distribution
- 69% of the sources lean Left
To view factuality data please Upgrade to Premium
